Slide 1: Third Quarter Earnings - Celanese 3Q 2005 Earnings
Third Quarter Earnings Celanese 3Q 2005 Earnings NYSE: CE Conference Call/Webcast Monday, November 7, 2005 12 p.m. CT Dave Weidman, CEO John J. Gallagher III, CFO 1 Forward Looking Statements, Reconciliation and Use of Non-GAAP Measures to U.S. GAAP This presentation may contain “forward-looking sta
Slide 2: Strong Underlying Business Results; Recent Business Achievements
President and Chief Executive Officer 3 Strong Underlying Business Results (in $millions) 3rd Qtr 2005 Net Sales $1,536 up 21% Operating Profit $92 up 268% Adjusted Diluted EPS $0.49 Dividends from Equity & Cost Investments $47 up 50% Adjusted EBITDA $253 up 16% Expansion of operating profit despite
Slide 3: Financial Highlights
5 John J. Gallagher III Executive Vice President and Chief Financial Officer 6 Financial Highlights in $ millions (except per share data) 3rd Qtr 2005 3rd Qtr 2004 Net Sales 1,536 1,265 SG&A (144) (153) Operating Profit 92 25 Net Earnings (Loss) 45 (71) Basic EPS 0.26 n.m. Special Items Special char
Slide 4: Chemical Products and Ticona Summaries
Chemicals Products (in $millions) 3rd Qtr 2005 Net Sales $1,100 up 31% Segment Earnings(1) $134 up 34% Third Quarter: Earnings increase on high utilization, continued favorable industry dynamics Pricing more than offset higher raw material costs in basic businesses; margin compression in downstream
Slide 5: Performance Products; Equity and Cost Investments; Capitalization
Performance Products (in $millions) 3rd Qtr 2005 Net Sales $46 down 2% Segment Earnings(1) $10 down 1% Stable earnings on strong sweetener demand Pricing declines consistent with strategy on sales to large-volume customers Attractive, cash generating businesses (1) –Earnings from continuing operatio
Slide 6: Combined Business Outlook
Net Debt (Total Debt Less Cash) 2,549 2,434 3,095 * Translated at 1.2042 - effective date Sept. 30, 2005 12 Combined Business Outlook Full Year 2005 Adjusted EPS to increase to $1.95 to $2.05 – up from previous guidance of $1.90 to $2.00 per share Includes positive impact of 98% ownership of Celanes